Agilent Jan 8, 2026 Agilent Technologies, Inc. $A Shares Purchased by Noesis Capital Mangement Corp - MarketBeat
Endpoints News Jan 8, 2026 Ollin’s drug clears retinal disease better than Roche’s Vabysmo in Phase 1b trial
PharmaVoice Jan 8, 2026 Billionaire Sean Parker has already shaken up cancer R&D. Can his nonprofit fix the funding gap?
FierceBiotech Jan 8, 2026 Immuneering touts 64% 1-year survival, keeping wheels turning in race with Revolution
FierceBiotech Jan 8, 2026 Diagonal moves forward with $125M series B round, plots first-in-human study this year
Agilent Jan 8, 2026 Agilent Technologies, Inc. (NYSE:A) Shares Could Be 30% Above Their Intrinsic Value Estimate - Yahoo Finance
Endpoints News Jan 8, 2026 French biotech Enodia gets €20.7M aided by Pfizer for protein degrader work
Endpoints News Jan 8, 2026 Charles Fuchs leaves Roche to steer ADC pipeline at Tubulis shortly after $401M Series C
Endpoints News Jan 8, 2026 Former Genentech leaders’ protein degrader startup EpiBiologics nets $107M